Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Cadello is a newly produced category-defining unique spirit produced by Distilleria Pisoni, a 150-year-old distillery in Italy. It is growing its distributors over the UK as well as Italy. The company has also partnered with Honest Grapes and other independent marketers and sales teams. Cadello has hired Italian and UK Brand Ambassadors and engaged Pegasus Spirits as UK importer and brand manager. The company will support its continued fast-paced growth by investing into its marketing and sales through tradeshows & tasting events, Brand Ambassadors, PR (editorial and events), social media & advertising, and bartending competitions.
days to go:
Expired
investment:
£275,490
Mous, an award-winning brand, has sold over 4 million accessories to 1.8 million customers, generating £24 million in annual sales as of March 2023. They aspire to become a household name in the £180 billion ($228 billion) global tech accessory market. With an in-house team of product experts, they create high-performance tech accessories and use impactful content, including extreme product demos, to promote their brand and products, resulting in millions of online views and followers. This fundraising round will help expand their product lines, particularly in backpacks and phone cases, including super-thin, recycled, and artist collaboration designs. They've also secured investment from BrewDog's founder and CEO through Crowdcube's 'The Next Unicorn' initiative.
days to go:
Expired
investment:
£1,614,153
Agile Store Builder allows you create your very own worldwide network of multiple stores by country, language, domain and product. These are all collectively managed in one system. You can also create stores for partners and affiliates to sell your products on a commission basis.
days to go:
Expired
investment:
£261
Widewalls is an online platform where art lovers discover and collect modern and contemporary art. In a nutshell, this platform connects art collectors and art dealers. Widewalls presents 3000 art venues, 12,000 artist profiles, and 19,000 articles covering modern and Contemporary art. This platform displays 20,000 artworks to discover and auctions results covering approximately 80% of the market over the past 4 years. In total, more than 120,000 pages on Widewalls are indexed by Google. It is the media partner of 48 international art fairs. The company's mission is to help traditional galleries and auction houses access and serve the online market more efficiently.
days to go:
Expired
investment:
£235,490
